Stem Cell Therapies Market

Stem Cell Therapies Market by Type, Therapeutic Application, Cell Source & Region - Forecast 2022 - 2032

Market Insights on Stem Cell Therapies covering sales outlook, demand forecast and up-to-date key trends

Request Sample

Stem Cell Therapies Market Overview (2022-2032)

[250 Pages Report] The stem cell therapy market is expected to grow at a CAGR of 16.7% to USD 401 million by 2026, up from USD 187 million in 2021.

Attributes	Details
Stem Cell Therapy Market (CAGR)	16.7%
Stem Cell Therapy Market (2026)	USD 401 million
Stem Cell Therapy Market (2021)	USD 187 million

Factors such as expanding stem cell research activities and increasing approvals of GMP-certified facilities to generate stem cells are driving stem cell therapy market expansion.

In the next years, the growing need for iPSCs as an alternative to ESCs, as well as the expanding demand for cell and gene treatments, are projected to promote the expansion of the stem cell therapy market.

What has been the Impact of COVID-19 on Stem Cell Therapy Market?

On March 11, 2020, the World Health Organization (WHO) proclaimed COVID-19 a pandemic. To combat the epidemic, researchers have been developing novel cures and treatments. Stem cells have been shown to be a successful treatment for pulmonary illnesses, especially COVID-19, in recent years.

At least 10 projects have been registered in the official international registry for clinical trials, implicating the use of mesenchymal stem cells to patients with coronavirus pneumonia hence increasing the demand for stem cell therapy and sales of stem cell therapy.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

What are the Drivers Contributing to the Growth of the Stem Cell Therapy Market?

The demand for innovative and better medicines to treat autoimmune, neurological, and cardiovascular disorders has led to a surge in demand for stem cell therapy and sales of stem cell therapy and research activity and funding for cell-based research.

Ethical considerations about embryonic stem cells are a source of restraint for the stem cell therapy market.

As stem cells are obtained by killing a human embryo, several ethical concerns are involved with the demand for stem cell therapy. A human embryo is seen as potential life, and eliminating them is considered immoral even if it can save a human life. Concerns about using embryonic stem cells to produce stem cell therapies limit stem cell therapy market expansion and the sales of stem cell therapy.

What are the Future Opportunities of the Stem Cell Therapy Market?

Adult stem cells that have been genetically reprogrammed to resemble embryonic stem cells are known as induced pluripotent stem cells (iPSCs). iPSCs are becoming a viable alternative to ESCs for the stem cell therapy market.

ESCs are involved with socio-ethical concerns and legislation about contraception, abortion, and in vitro fertilization since they are derived from early-stage embryos. The use of iPSCs avoids using human embryos, eliminating social and ethical concerns surging the demand for stem cell therapy with increased sales of stem cell therapy.

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What is the Regional Outlook of Stem Cell Therapy Market?

North America, Asia Pacific, and Europe accounted for the highest proportion of the stem cell therapy market.

This geographical segment's substantial proportion of the stem cell therapy market is largely due to the increased public-private financing and research grants for producing safe and effective stem cell treatment products, as well as the expanding number of clinical trials, can be ascribed to North America's major part of the stem cell therapy market with increased sales of stem cell therapy.

How is the Stem Cell Therapy Market Segmented based on Type?

Allogeneic stem cell treatment had the prominent demand for stem cell therapy and sales of stem cell therapy.

The stem cell therapy market is divided into two types, i.e., allogeneic stem cell therapy and autologous stem cell therapy. The allogeneic category held the most significant proportion for demand for stem cell therapy in the stem cell therapy market.

The simplicity of manufacturing and production methods, as well as the increased availability of innovative stem cell products across critical countries, are contributing to the allogeneic segment's rise in the stem cell therapy market.

How is the Stem Cell Therapy Market Segmented on the basis of Therapeutic Application?

During the predicted period, the sector of inflammatory and autoimmune illnesses will have the highest sales of stem cell therapy.

The stem cell therapy market is divided into musculoskeletal disorders, wounds and injuries, cardiovascular illnesses, surgeries, inflammatory and autoimmune diseases, neurological disorders, and other therapeutic applications based on therapeutic.

Due to the rising frequency of neurological illnesses and the high cost of therapy, the sales of stem cell therapy and demand for stem cell therapy neurological disorders category are predicted to increase at the fastest CAGR over the forecast period.

How is the Stem Cell Therapy Market Segmented on the basis of End Use?

Hospitals and research institutes are partnering to improve treatment options, therefore, escalat6ing demand for stem cell therapy along with sales of stem cell therapy.

The end-use category of hospitals is expected to grow by roughly 10.6% through 2027.

The stem cell therapy market is growing because of a growing demand for stem cell therapy and sales of stem cell therapy in hospitals to minimize difficulties caused by intrusive approaches such as surgical procedures.

Hospitals are associated with research facilities and academic institutes that do considerable research to develop novel stem cell therapy. Collaborations with research institutions enable hospitals to improve their treatment options and, as a result, have a favorable impact on stem cell therapy market statistics.

Who are the Key Market Players of the Stem Cell Therapy Market?

Key players in the stem cell therapy market include Smith & Nephew (UK, MEDIPOST Co., Ltd. (South Korea), Anterogen Co., Ltd. (South Korea), PHARMICELL Co., Ltd. (South Korea), JCR Pharmaceuticals Co., Ltd. (Japan), and NuVasive, Inc. (US).

In March 2021, Novadip Biosciences received approval from U.S. FDA for the Company's Investigational New Drug (IND) application for its autologous cell therapy product NVD-003. The product is used to treat Congenital Pseudarthrosis of the Tibia (CPT).

This strategy is likely to enhance its product offerings and expand its customer base as well as sales of stem cell therapy and demand for stem cell therapy, thereby strengthening its position in the stem cell therapy market.

In August 2020, Cipla and Stempeutics collaborated to launch Stempucel cell therapy to treat critical limb ischemia to grab the largest stem cell therapy market share.

Scope Of Report

Report Attribute	Details
Growth rate	CAGR of 16.7% from 2022 to 2032
Base year for estimation	2021
Historical data	2015 – 2020
Forecast period	2022 – 2032
Quantitative units	Revenue in USD million, volume in kilotons, and CAGR from 2022 to 2032
Report coverage	Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis,
Segments covered	Type, application, cell source, region
Regional scope	North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand
Country scope	U.S.; Canada; Mexico; Germany; U.K.; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa
Key companies profiled	Smith & Nephew (UK), MEDIPOST Co., Ltd. (South Korea), Anterogen Co., Ltd. (South Korea), PHARMICELL Co., Ltd. (South Korea), JCR Pharmaceuticals Co., Ltd. (Japan), and NuVasive, Inc. (US)
Customization scope	Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs.

Key Segments

By Type:

Allogeneic
Autologous

By Therapeutic Application:

Musculoskeletal
Wound & Injury
CVD
Autoimmune & Inflammatory

By Cell Source:

Adipose tissue
Bone Marrow
Placenta/Umbilical Cord

By Region:

North America
Latin America
Asia Pacific
MEA
Europe

Frequently Asked Questions

What was the Valuation of Stem Cell Therapy Market in North America?

North America stem cell therapy market valued at USD 3.7 billion in 2020 and is forecast to expand at 10.3% CAGR.

What is the Demand for Stem Cell Therapy in the End Use Category?

The end-use category of hospitals is expected to grow by roughly 10.6% with escalated demand for stem cell therapy

Which Segment by Type has the Highest Stem Cell Therapy Market Share?

Oncology segment accounted for about 37.1% of the stem cell therapy market share.

Which Segment has the Fastest Growth in the Stem Cell Therapy Market Share?

Autologous segment in stem cell therapy market is projected to grow with a stem cell therapy market share of around 10.5%.

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand-side Trends

1.3. Supply-side Trends

1.4. Technology Roadmap Analysis

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Market Dynamics

3.1.1. Drivers

3.1.2. Restraints

3.1.3. Opportunity

3.1.4. Trends

3.2. Scenario Forecast

3.2.1. Demand in Optimistic Scenario

3.2.2. Demand in Likely Scenario

3.2.3. Demand in Conservative Scenario

3.3. Opportunity Map Analysis

3.4. Investment Feasibility Matrix

3.5. PESTLE and Porter’s Analysis

3.6. Regulatory Landscape

3.6.1. By Key Regions

3.6.2. By Key Countries

3.7. Regional Parent Market Outlook

4. Global Market Analysis 2017-2021 and Forecast, 2022-2032

4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021

4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

4.2.1. Y-o-Y Growth Trend Analysis

4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Therapy Type

5.1. Introduction / Key Findings

5.2. Historical Market Size Value (US$ Mn) Analysis By Therapy Type, 2017-2021

5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Therapy Type, 2022-2032

5.3.1. Allogeneic Therapy

5.3.2. Autologous Therapy

5.4. Y-o-Y Growth Trend Analysis By Therapy Type, 2017-2021

5.5. Absolute $ Opportunity Analysis By Therapy Type, 2022-2032

Deep-dive segmentation will be available in the sample on request

6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Indication

6.1. Introduction / Key Findings

6.2. Historical Market Size Value (US$ Mn) Analysis By Indication, 2017-2021

6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Indication, 2022-2032

6.3.1. Autoimmune Diseases

6.3.2. Musculoskeletal Disorders

6.3.3. Acute Graft Host Disease

6.3.4. Trauma Injuries

6.3.5. Others

6.4. Y-o-Y Growth Trend Analysis By Indication, 2017-2021

6.5. Absolute $ Opportunity Analysis By Indication, 2022-2032

Deep-dive segmentation will be available in the sample on request

7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By End User

7.1. Introduction / Key Findings

7.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021

7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032

7.3.1. Hospitals

7.3.2. Acute Care Facilities

7.3.3. Specialized Clinics

7.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021

7.5. Absolute $ Opportunity Analysis By End User, 2022-2032

Deep-dive segmentation will be available in the sample on request

8. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Stem Cell Type

8.1. Introduction / Key Findings

8.2. Historical Market Size Value (US$ Mn) Analysis By Stem Cell Type, 2017-2021

8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Stem Cell Type, 2022-2032

8.3.1. Embryonic Stem Cells

8.3.2. Tissue-specific Stem Cells

8.3.3. Mesenchymal Stem Cells

8.3.4. Induced Pluripotent Stem Cells

8.4. Y-o-Y Growth Trend Analysis By Stem Cell Type, 2017-2021

8.5. Absolute $ Opportunity Analysis By Stem Cell Type, 2022-2032

Deep-dive segmentation will be available in the sample on request

9. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region

9.1. Introduction

9.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021

9.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

9.3.1. North America

9.3.2. Latin America

9.3.3. Europe

9.3.4. East Asia

9.3.5. South Asia & Pacific

9.3.6. MEA

9.4. Market Attractiveness Analysis By Region

10. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country

10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

10.2.1. By Country

10.2.1.1. U.K.

10.2.1.2. Canada

10.2.2. By Therapy Type

10.2.3. By Indication

10.2.4. By End User

10.2.5. By Stem Cell Type

10.3. Market Attractiveness Analysis

10.3.1. By Country

10.3.2. By Therapy Type

10.3.3. By Indication

10.3.4. By End User

10.3.5. By Stem Cell Type

10.4. Key Takeaways

11. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country

11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

11.2.1. By Country

11.2.1.1. Brazil

11.2.1.2. Mexico

11.2.1.3. Rest of Latin America

11.2.2. By Therapy Type

11.2.3. By Indication

11.2.4. By End User

11.2.5. By Stem Cell Type

11.3. Market Attractiveness Analysis

11.3.1. By Country

11.3.2. By Therapy Type

11.3.3. By Indication

11.3.4. By End User

11.3.5. By Stem Cell Type

11.4. Key Takeaways

12. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country

12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

12.2.1. By Country

12.2.1.1. Germany

12.2.1.2. U.K.

12.2.1.3. France

12.2.1.4. Spain

12.2.1.5. Italy

12.2.1.6. Rest of Europe

12.2.2. By Therapy Type

12.2.3. By Indication

12.2.4. By End User

12.2.5. By Stem Cell Type

12.3. Market Attractiveness Analysis

12.3.1. By Country

12.3.2. By Therapy Type

12.3.3. By Indication

12.3.4. By End User

12.3.5. By Stem Cell Type

12.4. Key Takeaways

13. East Asia Market Analysis 2017-2021 and Forecast 2022-2032, By Country

13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

13.2.1. By Country

13.2.1.1. China

13.2.1.2. Japan

13.2.1.3. South Korea

13.2.2. By Therapy Type

13.2.3. By Indication

13.2.4. By End User

13.2.5. By Stem Cell Type

13.3. Market Attractiveness Analysis

13.3.1. By Country

13.3.2. By Therapy Type

13.3.3. By Indication

13.3.4. By End User

13.3.5. By Stem Cell Type

13.4. Key Takeaways

14. South Asia & Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country

14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

14.2.1. By Country

14.2.1.1. India

14.2.1.2. Thailand

14.2.1.3. Indonesia

14.2.1.4. Malaysia

14.2.1.5. Singapore

14.2.1.6. Australia

14.2.1.7. New Zealand

14.2.1.8. Rest of South Asia & Pacific

14.2.2. By Therapy Type

14.2.3. By Indication

14.2.4. By End User

14.2.5. By Stem Cell Type

14.3. Market Attractiveness Analysis

14.3.1. By Country

14.3.2. By Therapy Type

14.3.3. By Indication

14.3.4. By End User

14.3.5. By Stem Cell Type

14.4. Key Takeaways

15. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country

15.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

15.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

15.2.1. By Country

15.2.1.1. GCC Countries

15.2.1.2. South Africa

15.2.1.3. Israel

15.2.1.4. Rest of MEA

15.2.2. By Therapy Type

15.2.3. By Indication

15.2.4. By End User

15.2.5. By Stem Cell Type

15.3. Market Attractiveness Analysis

15.3.1. By Country

15.3.2. By Therapy Type

15.3.3. By Indication

15.3.4. By End User

15.3.5. By Stem Cell Type

15.4. Key Takeaways

16. Key Countries Market Analysis

16.1. U.K.

16.1.1. Pricing Analysis

16.1.2. Market Share Analysis, 2021

16.1.2.1. By Therapy Type

16.1.2.2. By Indication

16.1.2.3. By End User

16.1.2.4. By Stem Cell Type

16.2. Canada

16.2.1. Pricing Analysis

16.2.2. Market Share Analysis, 2021

16.2.2.1. By Therapy Type

16.2.2.2. By Indication

16.2.2.3. By End User

16.2.2.4. By Stem Cell Type

16.3. Brazil

16.3.1. Pricing Analysis

16.3.2. Market Share Analysis, 2021

16.3.2.1. By Therapy Type

16.3.2.2. By Indication

16.3.2.3. By End User

16.3.2.4. By Stem Cell Type

16.4. Mexico

16.4.1. Pricing Analysis

16.4.2. Market Share Analysis, 2021

16.4.2.1. By Therapy Type

16.4.2.2. By Indication

16.4.2.3. By End User

16.4.2.4. By Stem Cell Type

16.5. Germany

16.5.1. Pricing Analysis

16.5.2. Market Share Analysis, 2021

16.5.2.1. By Therapy Type

16.5.2.2. By Indication

16.5.2.3. By End User

16.5.2.4. By Stem Cell Type

16.6. U.K.

16.6.1. Pricing Analysis

16.6.2. Market Share Analysis, 2021

16.6.2.1. By Therapy Type

16.6.2.2. By Indication

16.6.2.3. By End User

16.6.2.4. By Stem Cell Type

16.7. France

16.7.1. Pricing Analysis

16.7.2. Market Share Analysis, 2021

16.7.2.1. By Therapy Type

16.7.2.2. By Indication

16.7.2.3. By End User

16.7.2.4. By Stem Cell Type

16.8. Spain

16.8.1. Pricing Analysis

16.8.2. Market Share Analysis, 2021

16.8.2.1. By Therapy Type

16.8.2.2. By Indication

16.8.2.3. By End User

16.8.2.4. By Stem Cell Type

16.9. Italy

16.9.1. Pricing Analysis

16.9.2. Market Share Analysis, 2021

16.9.2.1. By Therapy Type

16.9.2.2. By Indication

16.9.2.3. By End User

16.9.2.4. By Stem Cell Type

16.10. China

16.10.1. Pricing Analysis

16.10.2. Market Share Analysis, 2021

16.10.2.1. By Therapy Type

16.10.2.2. By Indication

16.10.2.3. By End User

16.10.2.4. By Stem Cell Type

16.11. Japan

16.11.1. Pricing Analysis

16.11.2. Market Share Analysis, 2021

16.11.2.1. By Therapy Type

16.11.2.2. By Indication

16.11.2.3. By End User

16.11.2.4. By Stem Cell Type

16.12. South Korea

16.12.1. Pricing Analysis

16.12.2. Market Share Analysis, 2021

16.12.2.1. By Therapy Type

16.12.2.2. By Indication

16.12.2.3. By End User

16.12.2.4. By Stem Cell Type

16.13. India

16.13.1. Pricing Analysis

16.13.2. Market Share Analysis, 2021

16.13.2.1. By Therapy Type

16.13.2.2. By Indication

16.13.2.3. By End User

16.13.2.4. By Stem Cell Type

16.14. Thailand

16.14.1. Pricing Analysis

16.14.2. Market Share Analysis, 2021

16.14.2.1. By Therapy Type

16.14.2.2. By Indication

16.14.2.3. By End User

16.14.2.4. By Stem Cell Type

16.15. Indonesia

16.15.1. Pricing Analysis

16.15.2. Market Share Analysis, 2021

16.15.2.1. By Therapy Type

16.15.2.2. By Indication

16.15.2.3. By End User

16.15.2.4. By Stem Cell Type

16.16. Malaysia

16.16.1. Pricing Analysis

16.16.2. Market Share Analysis, 2021

16.16.2.1. By Therapy Type

16.16.2.2. By Indication

16.16.2.3. By End User

16.16.2.4. By Stem Cell Type

16.17. Singapore

16.17.1. Pricing Analysis

16.17.2. Market Share Analysis, 2021

16.17.2.1. By Therapy Type

16.17.2.2. By Indication

16.17.2.3. By End User

16.17.2.4. By Stem Cell Type

16.18. Australia

16.18.1. Pricing Analysis

16.18.2. Market Share Analysis, 2021

16.18.2.1. By Therapy Type

16.18.2.2. By Indication

16.18.2.3. By End User

16.18.2.4. By Stem Cell Type

16.19. New Zealand

16.19.1. Pricing Analysis

16.19.2. Market Share Analysis, 2021

16.19.2.1. By Therapy Type

16.19.2.2. By Indication

16.19.2.3. By End User

16.19.2.4. By Stem Cell Type

16.20. GCC Countries

16.20.1. Pricing Analysis

16.20.2. Market Share Analysis, 2021

16.20.2.1. By Therapy Type

16.20.2.2. By Indication

16.20.2.3. By End User

16.20.2.4. By Stem Cell Type

16.21. South Africa

16.21.1. Pricing Analysis

16.21.2. Market Share Analysis, 2021

16.21.2.1. By Therapy Type

16.21.2.2. By Indication

16.21.2.3. By End User

16.21.2.4. By Stem Cell Type

16.22. Israel

16.22.1. Pricing Analysis

16.22.2. Market Share Analysis, 2021

16.22.2.1. By Therapy Type

16.22.2.2. By Indication

16.22.2.3. By End User

16.22.2.4. By Stem Cell Type

17. Market Structure Analysis

17.1. Competition Dashboard

17.2. Competition Benchmarking

17.3. Market Share Analysis of Top Players

17.3.1. By Regional

17.3.2. By Therapy Type

17.3.3. By Indication

17.3.4. By End User

17.3.5. By Stem Cell Type

18. Competition Analysis

18.1. Competition Deep Dive

18.1.1. Vericel Corporation

18.1.1.1. Overview

18.1.1.2. Product Portfolio

18.1.1.3. Profitability by Market Segments

18.1.1.4. Sales Footprint

18.1.1.5. Strategy Overview

18.1.1.5.1. Marketing Strategy

18.1.2. Cyagen Biosciences, Inc.

18.1.2.1. Overview

18.1.2.2. Product Portfolio

18.1.2.3. Profitability by Market Segments

18.1.2.4. Sales Footprint

18.1.2.5. Strategy Overview

18.1.2.5.1. Marketing Strategy

18.1.3. Stemcell Technologies Inc.

18.1.3.1. Overview

18.1.3.2. Product Portfolio

18.1.3.3. Profitability by Market Segments

18.1.3.4. Sales Footprint

18.1.3.5. Strategy Overview

18.1.3.5.1. Marketing Strategy

18.1.4. Celegene Corporation

18.1.4.1. Overview

18.1.4.2. Product Portfolio

18.1.4.3. Profitability by Market Segments

18.1.4.4. Sales Footprint

18.1.4.5. Strategy Overview

18.1.4.5.1. Marketing Strategy

18.1.5. Cellular Dynamics International

18.1.5.1. Overview

18.1.5.2. Product Portfolio

18.1.5.3. Profitability by Market Segments

18.1.5.4. Sales Footprint

18.1.5.5. Strategy Overview

18.1.5.5.1. Marketing Strategy

18.1.6. Cytori Therapeutics, Inc.

18.1.6.1. Overview

18.1.6.2. Product Portfolio

18.1.6.3. Profitability by Market Segments

18.1.6.4. Sales Footprint

18.1.6.5. Strategy Overview

18.1.6.5.1. Marketing Strategy

18.1.7. Fibrocell Science, Inc.

18.1.7.1. Overview

18.1.7.2. Product Portfolio

18.1.7.3. Profitability by Market Segments

18.1.7.4. Sales Footprint

18.1.7.5. Strategy Overview

18.1.7.5.1. Marketing Strategy

18.1.8. Mesoblast Ltd

18.1.8.1. Overview

18.1.8.2. Product Portfolio

18.1.8.3. Profitability by Market Segments

18.1.8.4. Sales Footprint

18.1.8.5. Strategy Overview

18.1.8.5.1. Marketing Strategy

18.1.9. Regeneus Ltd

18.1.9.1. Overview

18.1.9.2. Product Portfolio

18.1.9.3. Profitability by Market Segments

18.1.9.4. Sales Footprint

18.1.9.5. Strategy Overview

18.1.9.5.1. Marketing Strategy

18.1.10. EMD Millipore Corporation

18.1.10.1. Overview

18.1.10.2. Product Portfolio

18.1.10.3. Profitability by Market Segments

18.1.10.4. Sales Footprint

18.1.10.5. Strategy Overview

18.1.10.5.1. Marketing Strategy

18.1.11. ReNeuron Group plc

18.1.11.1. Overview

18.1.11.2. Product Portfolio

18.1.11.3. Profitability by Market Segments

18.1.11.4. Sales Footprint

18.1.11.5. Strategy Overview

18.1.11.5.1. Marketing Strategy

18.1.12. International Stem Cell Corporation

18.1.12.1. Overview

18.1.12.2. Product Portfolio

18.1.12.3. Profitability by Market Segments

18.1.12.4. Sales Footprint

18.1.12.5. Strategy Overview

18.1.12.5.1. Marketing Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

List of Tables

Table 1: Global Market Value (US$ Mn) Forecast by Region, 2017-2032

Table 2: Global Market Value (US$ Mn) Forecast by Therapy Type, 2017-2032

Table 3: Global Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 4: Global Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 5: Global Market Value (US$ Mn) Forecast by Stem Cell Type, 2017-2032

Table 6: North America Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 7: North America Market Value (US$ Mn) Forecast by Therapy Type, 2017-2032

Table 8: North America Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 9: North America Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 10: North America Market Value (US$ Mn) Forecast by Stem Cell Type, 2017-2032

Table 11: Latin America Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 12: Latin America Market Value (US$ Mn) Forecast by Therapy Type, 2017-2032

Table 13: Latin America Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 14: Latin America Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 15: Latin America Market Value (US$ Mn) Forecast by Stem Cell Type, 2017-2032

Table 16: Europe Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 17: Europe Market Value (US$ Mn) Forecast by Therapy Type, 2017-2032

Table 18: Europe Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 19: Europe Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 20: Europe Market Value (US$ Mn) Forecast by Stem Cell Type, 2017-2032

Table 21: East Asia Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 22: East Asia Market Value (US$ Mn) Forecast by Therapy Type, 2017-2032

Table 23: East Asia Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 24: East Asia Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 25: East Asia Market Value (US$ Mn) Forecast by Stem Cell Type, 2017-2032

Table 26: South Asia & Pacific Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 27: South Asia & Pacific Market Value (US$ Mn) Forecast by Therapy Type, 2017-2032

Table 28: South Asia & Pacific Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 29: South Asia & Pacific Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 30: South Asia & Pacific Market Value (US$ Mn) Forecast by Stem Cell Type, 2017-2032

Table 31: MEA Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 32: MEA Market Value (US$ Mn) Forecast by Therapy Type, 2017-2032

Table 33: MEA Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 34: MEA Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 35: MEA Market Value (US$ Mn) Forecast by Stem Cell Type, 2017-2032

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

List of Charts

Figure 1: Global Market Value (US$ Mn) by Therapy Type, 2022-2032

Figure 2: Global Market Value (US$ Mn) by Indication, 2022-2032

Figure 3: Global Market Value (US$ Mn) by End User, 2022-2032

Figure 4: Global Market Value (US$ Mn) by Stem Cell Type, 2022-2032

Figure 5: Global Market Value (US$ Mn) by Region, 2022-2032

Figure 6: Global Market Value (US$ Mn) Analysis by Region, 2017-2032

Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 9: Global Market Value (US$ Mn) Analysis by Therapy Type, 2017-2032

Figure 10: Global Market Value Share (%) and BPS Analysis by Therapy Type, 2022-2032

Figure 11: Global Market Y-o-Y Growth (%) Projections by Therapy Type, 2022-2032

Figure 12: Global Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 13: Global Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 14: Global Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 15: Global Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 16: Global Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 17: Global Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 18: Global Market Value (US$ Mn) Analysis by Stem Cell Type, 2017-2032

Figure 19: Global Market Value Share (%) and BPS Analysis by Stem Cell Type, 2022-2032

Figure 20: Global Market Y-o-Y Growth (%) Projections by Stem Cell Type, 2022-2032

Figure 21: Global Market Attractiveness by Therapy Type, 2022-2032

Figure 22: Global Market Attractiveness by Indication, 2022-2032

Figure 23: Global Market Attractiveness by End User, 2022-2032

Figure 24: Global Market Attractiveness by Stem Cell Type, 2022-2032

Figure 25: Global Market Attractiveness by Region, 2022-2032

Figure 26: North America Market Value (US$ Mn) by Therapy Type, 2022-2032

Figure 27: North America Market Value (US$ Mn) by Indication, 2022-2032

Figure 28: North America Market Value (US$ Mn) by End User, 2022-2032

Figure 29: North America Market Value (US$ Mn) by Stem Cell Type, 2022-2032

Figure 30: North America Market Value (US$ Mn) by Country, 2022-2032

Figure 31: North America Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 32: North America Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 33: North America Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 34: North America Market Value (US$ Mn) Analysis by Therapy Type, 2017-2032

Figure 35: North America Market Value Share (%) and BPS Analysis by Therapy Type, 2022-2032

Figure 36: North America Market Y-o-Y Growth (%) Projections by Therapy Type, 2022-2032

Figure 37: North America Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 38: North America Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 39: North America Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 40: North America Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 41: North America Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 42: North America Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 43: North America Market Value (US$ Mn) Analysis by Stem Cell Type, 2017-2032

Figure 44: North America Market Value Share (%) and BPS Analysis by Stem Cell Type, 2022-2032

Figure 45: North America Market Y-o-Y Growth (%) Projections by Stem Cell Type, 2022-2032

Figure 46: North America Market Attractiveness by Therapy Type, 2022-2032

Figure 47: North America Market Attractiveness by Indication, 2022-2032

Figure 48: North America Market Attractiveness by End User, 2022-2032

Figure 49: North America Market Attractiveness by Stem Cell Type, 2022-2032

Figure 50: North America Market Attractiveness by Country, 2022-2032

Figure 51: Latin America Market Value (US$ Mn) by Therapy Type, 2022-2032

Figure 52: Latin America Market Value (US$ Mn) by Indication, 2022-2032

Figure 53: Latin America Market Value (US$ Mn) by End User, 2022-2032

Figure 54: Latin America Market Value (US$ Mn) by Stem Cell Type, 2022-2032

Figure 55: Latin America Market Value (US$ Mn) by Country, 2022-2032

Figure 56: Latin America Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 57: Latin America Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 58: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 59: Latin America Market Value (US$ Mn) Analysis by Therapy Type, 2017-2032

Figure 60: Latin America Market Value Share (%) and BPS Analysis by Therapy Type, 2022-2032

Figure 61: Latin America Market Y-o-Y Growth (%) Projections by Therapy Type, 2022-2032

Figure 62: Latin America Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 63: Latin America Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 65: Latin America Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 66: Latin America Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 67: Latin America Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 68: Latin America Market Value (US$ Mn) Analysis by Stem Cell Type, 2017-2032

Figure 69: Latin America Market Value Share (%) and BPS Analysis by Stem Cell Type, 2022-2032

Figure 70: Latin America Market Y-o-Y Growth (%) Projections by Stem Cell Type, 2022-2032

Figure 71: Latin America Market Attractiveness by Therapy Type, 2022-2032

Figure 72: Latin America Market Attractiveness by Indication, 2022-2032

Figure 73: Latin America Market Attractiveness by End User, 2022-2032

Figure 74: Latin America Market Attractiveness by Stem Cell Type, 2022-2032

Figure 75: Latin America Market Attractiveness by Country, 2022-2032

Figure 76: Europe Market Value (US$ Mn) by Therapy Type, 2022-2032

Figure 77: Europe Market Value (US$ Mn) by Indication, 2022-2032

Figure 78: Europe Market Value (US$ Mn) by End User, 2022-2032

Figure 79: Europe Market Value (US$ Mn) by Stem Cell Type, 2022-2032

Figure 80: Europe Market Value (US$ Mn) by Country, 2022-2032

Figure 81: Europe Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 82: Europe Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 83: Europe Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 84: Europe Market Value (US$ Mn) Analysis by Therapy Type, 2017-2032

Figure 85: Europe Market Value Share (%) and BPS Analysis by Therapy Type, 2022-2032

Figure 86: Europe Market Y-o-Y Growth (%) Projections by Therapy Type, 2022-2032

Figure 87: Europe Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 88: Europe Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 89: Europe Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 90: Europe Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 91: Europe Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 92: Europe Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 93: Europe Market Value (US$ Mn) Analysis by Stem Cell Type, 2017-2032

Figure 94: Europe Market Value Share (%) and BPS Analysis by Stem Cell Type, 2022-2032

Figure 95: Europe Market Y-o-Y Growth (%) Projections by Stem Cell Type, 2022-2032

Figure 96: Europe Market Attractiveness by Therapy Type, 2022-2032

Figure 97: Europe Market Attractiveness by Indication, 2022-2032

Figure 98: Europe Market Attractiveness by End User, 2022-2032

Figure 99: Europe Market Attractiveness by Stem Cell Type, 2022-2032

Figure 100: Europe Market Attractiveness by Country, 2022-2032

Figure 101: East Asia Market Value (US$ Mn) by Therapy Type, 2022-2032

Figure 102: East Asia Market Value (US$ Mn) by Indication, 2022-2032

Figure 103: East Asia Market Value (US$ Mn) by End User, 2022-2032

Figure 104: East Asia Market Value (US$ Mn) by Stem Cell Type, 2022-2032

Figure 105: East Asia Market Value (US$ Mn) by Country, 2022-2032

Figure 106: East Asia Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 107: East Asia Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 108: East Asia Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 109: East Asia Market Value (US$ Mn) Analysis by Therapy Type, 2017-2032

Figure 110: East Asia Market Value Share (%) and BPS Analysis by Therapy Type, 2022-2032

Figure 111: East Asia Market Y-o-Y Growth (%) Projections by Therapy Type, 2022-2032

Figure 112: East Asia Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 113: East Asia Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 114: East Asia Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 115: East Asia Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 116: East Asia Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 117: East Asia Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 118: East Asia Market Value (US$ Mn) Analysis by Stem Cell Type, 2017-2032

Figure 119: East Asia Market Value Share (%) and BPS Analysis by Stem Cell Type, 2022-2032

Figure 120: East Asia Market Y-o-Y Growth (%) Projections by Stem Cell Type, 2022-2032

Figure 121: East Asia Market Attractiveness by Therapy Type, 2022-2032

Figure 122: East Asia Market Attractiveness by Indication, 2022-2032

Figure 123: East Asia Market Attractiveness by End User, 2022-2032

Figure 124: East Asia Market Attractiveness by Stem Cell Type, 2022-2032

Figure 125: East Asia Market Attractiveness by Country, 2022-2032

Figure 126: South Asia & Pacific Market Value (US$ Mn) by Therapy Type, 2022-2032

Figure 127: South Asia & Pacific Market Value (US$ Mn) by Indication, 2022-2032

Figure 128: South Asia & Pacific Market Value (US$ Mn) by End User, 2022-2032

Figure 129: South Asia & Pacific Market Value (US$ Mn) by Stem Cell Type, 2022-2032

Figure 130: South Asia & Pacific Market Value (US$ Mn) by Country, 2022-2032

Figure 131: South Asia & Pacific Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 132: South Asia & Pacific Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 133: South Asia & Pacific Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 134: South Asia & Pacific Market Value (US$ Mn) Analysis by Therapy Type, 2017-2032

Figure 135: South Asia & Pacific Market Value Share (%) and BPS Analysis by Therapy Type, 2022-2032

Figure 136: South Asia & Pacific Market Y-o-Y Growth (%) Projections by Therapy Type, 2022-2032

Figure 137: South Asia & Pacific Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 138: South Asia & Pacific Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 139: South Asia & Pacific Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 140: South Asia & Pacific Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 141: South Asia & Pacific Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 142: South Asia & Pacific Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 143: South Asia & Pacific Market Value (US$ Mn) Analysis by Stem Cell Type, 2017-2032

Figure 144: South Asia & Pacific Market Value Share (%) and BPS Analysis by Stem Cell Type, 2022-2032

Figure 145: South Asia & Pacific Market Y-o-Y Growth (%) Projections by Stem Cell Type, 2022-2032

Figure 146: South Asia & Pacific Market Attractiveness by Therapy Type, 2022-2032

Figure 147: South Asia & Pacific Market Attractiveness by Indication, 2022-2032

Figure 148: South Asia & Pacific Market Attractiveness by End User, 2022-2032

Figure 149: South Asia & Pacific Market Attractiveness by Stem Cell Type, 2022-2032

Figure 150: South Asia & Pacific Market Attractiveness by Country, 2022-2032

Figure 151: MEA Market Value (US$ Mn) by Therapy Type, 2022-2032

Figure 152: MEA Market Value (US$ Mn) by Indication, 2022-2032

Figure 153: MEA Market Value (US$ Mn) by End User, 2022-2032

Figure 154: MEA Market Value (US$ Mn) by Stem Cell Type, 2022-2032

Figure 155: MEA Market Value (US$ Mn) by Country, 2022-2032

Figure 156: MEA Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 157: MEA Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 158: MEA Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 159: MEA Market Value (US$ Mn) Analysis by Therapy Type, 2017-2032

Figure 160: MEA Market Value Share (%) and BPS Analysis by Therapy Type, 2022-2032

Figure 161: MEA Market Y-o-Y Growth (%) Projections by Therapy Type, 2022-2032

Figure 162: MEA Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 163: MEA Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 164: MEA Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 165: MEA Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 166: MEA Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 167: MEA Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 168: MEA Market Value (US$ Mn) Analysis by Stem Cell Type, 2017-2032

Figure 169: MEA Market Value Share (%) and BPS Analysis by Stem Cell Type, 2022-2032

Figure 170: MEA Market Y-o-Y Growth (%) Projections by Stem Cell Type, 2022-2032

Figure 171: MEA Market Attractiveness by Therapy Type, 2022-2032

Figure 172: MEA Market Attractiveness by Indication, 2022-2032

Figure 173: MEA Market Attractiveness by End User, 2022-2032

Figure 174: MEA Market Attractiveness by Stem Cell Type, 2022-2032

Figure 175: MEA Market Attractiveness by Country, 2022-2032